Actualités FSD Pharma Inc - HUGE | Actions Canadian Securities Exchange

FSD Pharma Featured in CannaInvestor Magazine December Issue

FSD Pharma Featured in CannaInvestor Magazine December Issue Toronto, ON -- December 12, 2018 -- InvestorsHub NewsWire...

FSD Pharma Announces Collaboration and License Agreement with World Class Extractions

FSD Pharma Announces Collaboration and License Agreement with World Class Extractions TORONTO, ON -- December 6, 2018...

FSD Pharma Hits Over 4 Billion Shares Traded in First 6 Months

FSD PHARMA HITS OVER 4 BILLION SHARES TRADED IN FIRST 6 MONTHS Toronto, ON -- December 3, 2018 -- InvestrorsHub NewsWire...

FSD Pharma Reports Positive Q3 Results

FSD Pharma Reports Positive Q3 Results TORONTO, ON -- November 30, 2018 -- InvestorsHub NewsWire -- FSD Pharma Inc...

FSD Pharma and SciCann Therapeutics to Present at the iCDP Summit in Boston

FSD Pharma and SciCann Therapeutics to Present at the iCDP Summit in Boston Toronto -- November 29, 2018 -- InvestorsHub...

FSD Pharma Facility Valued at $105,000,000 with 3,000,000 FT. Expansion Assessed at $420,000,000

FSD Pharma Facility Valued at $105,000,000 with 3,000,000 FT. Expansion Assessed at $420,000,000 Toronto, ON...

FSD PHARMA Appoints Top GW Pharmaceuticals Executive, Rupert Haynes, as Chief Executive Officer

Management addition comes as FSD accelerates specialty cannabinoid pharmaceutical global expansion strategy ...

FSD PHARMA ADDS DAVID URBAN TO BOARD OF DIRECTORS

FSD PHARMA ADDS DAVID URBAN TO BOARD OF DIRECTORS Toronto -- November 14, 2018 -- InvestorsHub NewsWire -- FSD Pharma Inc. (“FSD...

FSD PHARMA RECEIVES LICENSE TO SELL TO OTHER LICENSED PRODUCERS AND EXPANDS GROWTH PRODUCTION FOOTPRINT

Toronto -- November 12, 2018 -- InvestorsHub NewsWire -- FSD Pharma Inc. (“FSD Pharma” or the...

FSD Pharma Announces Positive ISA Report For "Steady Stomach" CBD Combination

FSD Pharma Announces Positive ISA Report For “Steady Stomach” CBD Combination Toronto, ON -- November 6, 2018...

FSD Pharma Co-Chairman, Anthony Durkacz, Featured in Bloomberg Article

Toronto, ON -- October 30, 2018 -- InvestorsHub NewsWire Marijuana Shortages Abound in Canada Amid Application...

FSD Pharma Appoints Dr. Raza Bokhari as Interim CEO & Co-chairman, Anthony Durkacz as Co-Chairman & Zeeshan Saeed as President

Toronto, ON -- October 29, 2018 -- InvestorsHub NewsWire -- The Board of Directors of FSD Pharma Inc. (“FSD...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

FSD Pharma Inc (HUGE)

Votre Hub pour des idées et discussions en direct en temps réel

HUGE Actualités

FSD Pharma Featured in CannaInvestor Magazine December Issue

FSD Pharma Announces Collaboration and License Agreement with World Class Extractions

FSD Pharma Hits Over 4 Billion Shares Traded in First 6 Months

FSD Pharma Reports Positive Q3 Results

FSD Pharma and SciCann Therapeutics to Present at the iCDP Summit in Boston

FSD Pharma Facility Valued at $105,000,000 with 3,000,000 FT. Expansion Assessed at $420,000,000

FSD PHARMA Appoints Top GW Pharmaceuticals Executive, Rupert Haynes, as Chief Executive Officer

FSD PHARMA ADDS DAVID URBAN TO BOARD OF DIRECTORS

FSD PHARMA RECEIVES LICENSE TO SELL TO OTHER LICENSED PRODUCERS AND EXPANDS GROWTH PRODUCTION FOOTPRINT

FSD Pharma Announces Positive ISA Report For "Steady Stomach" CBD Combination

FSD Pharma Co-Chairman, Anthony Durkacz, Featured in Bloomberg Article

FSD Pharma Appoints Dr. Raza Bokhari as Interim CEO & Co-chairman, Anthony Durkacz as Co-Chairman & Zeeshan Saeed as President

FSD Pharma Announces Issuance of Cannabis License Under Excise Act

FSD Pharma Signs Binding LOI to Acquire Therapix Biosciences, a NASDAQ Traded Pharmaceutical Company

FSD Pharma Featured on CTV Toronto

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

FSD Pharma Inc (HUGE) Actualités

FSD Pharma Inc (HUGE)

Votre Hub pour des idées et discussions en direct en temps réel

HUGE Actualités

FSD Pharma Featured in CannaInvestor Magazine December Issue

FSD Pharma Announces Collaboration and License Agreement with World Class Extractions

FSD Pharma Hits Over 4 Billion Shares Traded in First 6 Months

FSD Pharma Reports Positive Q3 Results

FSD Pharma and SciCann Therapeutics to Present at the iCDP Summit in Boston

FSD Pharma Facility Valued at $105,000,000 with 3,000,000 FT. Expansion Assessed at $420,000,000

FSD PHARMA Appoints Top GW Pharmaceuticals Executive, Rupert Haynes, as Chief Executive Officer

FSD PHARMA ADDS DAVID URBAN TO BOARD OF DIRECTORS

FSD PHARMA RECEIVES LICENSE TO SELL TO OTHER LICENSED PRODUCERS AND EXPANDS GROWTH PRODUCTION FOOTPRINT

FSD Pharma Announces Positive ISA Report For "Steady Stomach" CBD Combination

FSD Pharma Co-Chairman, Anthony Durkacz, Featured in Bloomberg Article

FSD Pharma Appoints Dr. Raza Bokhari as Interim CEO & Co-chairman, Anthony Durkacz as Co-Chairman & Zeeshan Saeed as President

FSD Pharma Announces Issuance of Cannabis License Under Excise Act

FSD Pharma Signs Binding LOI to Acquire Therapix Biosciences, a NASDAQ Traded Pharmaceutical Company

FSD Pharma Featured on CTV Toronto

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application